Paper1900254
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
Marcellin P and 9 others. Hepatology, 1991. Cited by 352 papers, by iCite.
Cite this record
ConductScience Library. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Papers, record 1900254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1900254
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis C | Major topic |
| Interferon Type I | Major topic |
| Recombinant Proteins | Major topic |
| Adult | |
| Alanine Transaminase | |
| Female | |
| France | |
| Humans | |
| Male |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 1900256 | Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions? | https://conductscience.org/library/papers/1900256 |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 352 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31213010 | Humanized Mouse Models for the Study of Hepatitis C and Host Interactions. | Cells | 2019 | https://conductscience.org/library/papers/31213010 | PubMed |
| 23745021 | Sofosbuvir and ABT-450: terminator of hepatitis C virus? | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23745021 | PubMed |
| 18370481 | Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C. | Clin Drug Investig | 1998 | https://conductscience.org/library/papers/18370481 | PubMed |
| 16501853 | Antiviral therapy for chronic hepatitis C: past, present, and future. | J Gastroenterol | 2006 | https://conductscience.org/library/papers/16501853 | PubMed |
| 15546094 | Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15546094 | PubMed |
| 12498286 | Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis. | Dig Dis Sci | 2002 | https://conductscience.org/library/papers/12498286 | PubMed |
| 12076394 | Interferon for interferon naive patients with chronic hepatitis C. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12076394 | PubMed |
| 11678904 | IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C. | Clin Exp Immunol | 2001 | https://conductscience.org/library/papers/11678904 | PubMed |
| 11177692 | Pegylated interferons: what role will they play in the treatment of chronic hepatitis C? | Curr Gastroenterol Rep | 2001 | https://conductscience.org/library/papers/11177692 | PubMed |
| 10829940 | Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management. | Indian J Pediatr | 1995 | https://conductscience.org/library/papers/10829940 | PubMed |
| 10369715 | Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. | Gut | 1999 | https://conductscience.org/library/papers/10369715 | PubMed |
| 10363572 | Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10363572 | PubMed |
| 9733898 | Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene. | J Virol | 1998 | https://conductscience.org/library/papers/9733898 | PubMed |
| 9690395 | Value of liver biopsy prior to interferon therapy for chronic viral hepatitis. | Dig Dis Sci | 1998 | https://conductscience.org/library/papers/9690395 | PubMed |
| 9342559 | Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment. | Drugs Aging | 1997 | https://conductscience.org/library/papers/9342559 | PubMed |
| 9246043 | Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis. | Dig Dis Sci | 1997 | https://conductscience.org/library/papers/9246043 | PubMed |
| 9173207 | [Therapy of hepatitis C]. | Med Klin (Munich) | 1997 | https://conductscience.org/library/papers/9173207 | PubMed |
| 9058296 | Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial. | J Gastroenterol | 1997 | https://conductscience.org/library/papers/9058296 | PubMed |
| 9011483 | Two years versus six months of interferon therapy for chronic hepatitis C. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/9011483 | PubMed |
| 9011468 | Predictors of response to interferon therapy. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/9011468 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1900254
GET https://conductscience.org/api/papers/v1/1900254/cited_by?page=2